How to Discuss GLP-1 Side Effects with Your Doctor

    By Trimi Medical Team8 min read

    Many patients downplay their side effects or feel like they should "just push through." But your provider needs accurate information to help you. Untreated side effects lead to medication discontinuation, which means losing the weight loss benefits entirely. Here is how to communicate effectively about what you are experiencing.

    Medical Disclaimer: This article is for informational purposes only. Seek immediate medical attention for severe side effects including persistent vomiting, severe abdominal pain, or signs of pancreatitis.

    Before Your Appointment: Track Your Symptoms

    Your provider can help more effectively when you provide specific information:

    • What: Exact symptoms (nausea, vomiting, constipation, diarrhea, fatigue, headache)
    • When: Time of day, relation to injection day, relation to meals
    • How long: Duration of each episode
    • Severity: Rate 1-10, and whether it affects daily function
    • What helps: What you have tried and whether it worked

    Scripts for Common Situations

    Persistent Nausea

    "I have been experiencing nausea rated about [severity] out of 10, primarily on days [timeframe relative to injection]. It lasts approximately [duration]. I have tried [ginger, smaller meals, timing changes] with [limited/some/no] improvement. It is affecting my ability to [work/eat/exercise]. Can we discuss options like adjusting my dose or adding an anti-nausea medication?"

    Severe Constipation

    "I am having bowel movements only every [number] days since starting/increasing my dose. I have tried increasing fiber to [amount], drinking [amount] of water, and using [any OTC remedies]. It is causing [discomfort/bloating/pain]. What do you recommend?"

    Side Effects Affecting Quality of Life

    "I want to continue this medication because the weight loss benefits are important to me, but the side effects are significantly affecting my daily life. I am [missing work/unable to exercise/not eating enough/unable to socialize]. Can we discuss adjusting the dose, adding supportive medications, or changing the injection timing?"

    What Your Provider Can Do

    • Dose adjustment: Reduce to a better-tolerated dose or slow the titration schedule
    • Supportive medications: Ondansetron for nausea, stool softeners for constipation, acid reducers for reflux
    • Timing changes: Moving injection day or time may help
    • Medication switch: A different GLP-1 medication may have a different side effect profile
    • Lifestyle modifications: Specific dietary changes that reduce symptoms

    Get Responsive Medical Support with Trimi

    Trimi's providers are experienced with GLP-1 side effect management. Compounded semaglutide is $99/month and compounded tirzepatide is $125/month. Visit our treatment page to start.

    Frequently Asked Questions

    Should I stop my medication if side effects are severe?

    Contact your provider before stopping. They may recommend a temporary pause, dose reduction, or supportive treatment rather than complete discontinuation. If you are vomiting repeatedly, unable to keep fluids down, or experiencing severe abdominal pain, seek immediate medical attention.

    How do I know if a side effect is serious versus expected?

    Expected side effects (mild nausea, decreased appetite, mild constipation) are manageable and usually improve over time. Serious side effects requiring immediate attention include: severe persistent abdominal pain (possible pancreatitis), persistent vomiting leading to dehydration, vision changes, or allergic reactions.

    Will my provider think I am complaining too much?

    No. Reporting side effects is providing essential clinical information. Your provider needs this data to optimize your treatment. Underreporting side effects is far more problematic than overreporting.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Related Reading